SOLICITATION NOTICE
B -- Special Studies and Analysis
- Notice Date
- 8/29/2003
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, Contracts Operations Branch 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, MD, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-PS-2003-130
- Response Due
- 9/13/2003
- Archive Date
- 9/28/2003
- Point of Contact
- Cecilia Morales, Purchasing Agent, Phone (301) 435-0366, Fax (301) 480-3345,
- E-Mail Address
-
cm71f@nih.gov
- Description
- It is the intent of the National Heart, Lung, and Blood Institute (NHLBI) for the National Institutes on Drug Abuse (NIDA) Division of Treatment Research and Development (DTR&D) at the National Institutes of Health (NIH) to purchase service for the development of protocols using medication for smoking cessation, protocols to prevent relapse, and short and long term abstinence. The Statement of Work for the requirement is as follows: SPECIFIC REQUIREMENTS: 1) To prepare drafts and final copies (1-hard copy and 1-electronic copy) of the following in either Word Perfect or MS Word: A) Development of at least two (2) protocols for medications for smoking cessation in coordination with the NIDA Project Officer. B) Development of at least two (2) protocols to prevent relapse to smoking in coordination with the NIDA Project Officer. C) Development of at least two (2) documents to discuss the rationale of specific medications for the treatment of various indications for smoking cesstion: short and long-term abstinence and relapse prevention. This would be in coordination with the NIDA project officer. 2) To attend pharmaceutical companies meetings at the request of the NIDA Project Officer for development document packages to be used by DTR&D for discussion. At this time, it is anticipated that at least two (2) packages will be developed. 3) To attend Food and Drug Administration (FDA) meetings at the request of the NIDA Project Officer for development of document packages for the discussion with FDA officials. At this time, it is anticipated that at least two (2) packages will be developed. DELIVERABLES: 1) All deliverables are to be delivered to NIDA Project Officer listed below by requested date. 2) To prepare drafts and final copies (hard and electronic) copies of the following: A) Development of at least two (2) protocols for medications for smoking cessation in coordination with the NIDA Project Officer for draft. Final copy is due one (1) week after return of draft protocol from NIDA Project Officer. B) Development of at least two (2) protocols to prevent relapse to smoking in coordination with the NIDA Project Officer. Two (2) weeks after notification from NIDA Project Officer for draft. Final copy is due one (1) week after return of draft protocol from NIDA Project Officer. C) Development of at least two (2) documents to discuss the rationale of specific medications for the treatment of various indictions for smoking cessation: short and long-term abstinence and relapse prevention. This would be in coordination with the NIDA Project Officer for draft. Final copy is due one (1) week after return of draft protocol from NIDA Project Officer. D)To attend pharmaceutical companies meetings t the request of the NIDA Project Officer for development document packages to be used by DTR&D for discussion. At this time, it is anticipated that at least two (2) packages will be developed. Development of draft document packages shall be due to NIDA Project Officer two (2) weeks after meeting with pharmaceutical companies. Final copy will be due one (1) week after the return of draft by NIDA Project Officer. E) To attend Food and Drug Administration (FDA) meetings at the request of the NIDA Project Officer for development of document packages for the discussion with FDA officials. At this time, it is anticipated that at least two (2) packages will be developed. Development of draft document packages shall be due to NIDA Project Officer two (2) weeks after the meeting with FDA officials. Final copy will be due one week after the return of draft by NIDA Project Officer. SCHEDULE OF PERFORMANCE: The NIDA Project Officer will notify the contractor of the date when the protocols, document packages, or meetings will be due according to the deliverables. The period of performance will be from September 2003 to April 2004. SCHEDULE OF PAYMENT: Payments should be made every two (2) months for work that has been completed and certified by NIDA Project Officer. This requirement is under the North American Industry Classification System (NAICS) number 541710, size standard 500 employees. This acquisition is solicited as a total Small Business Set Aside. Proposals are due fifteen (15) calendar days from the publication date of this synopsis or September 13, 2003. Proposals must include the cost breakdown by hourly rate, Curriculum Vitae, Past performance experience with pharmaceutical industry background, and DUNS number. Proposals will be evaluated on conformance to the Government?s requirements and price. All responsible sources may submit a proposal which if timely received shall be considered by the agency. Proposals must be submitted in writing to the National Heart, Lung, and Blood Institute, Contracts Operations Branch, Procurement Section, Rockledge Building 2, Suite 6149, 6701 Rockledge Drive, Bethesda, Maryland 20817-7902, Attention: Ms. Cecilia Morales, Purchasing Agent. Fax proposals will only be accepted if dated and signed by an authorized company representative.
- Record
- SN00415990-W 20030831/030829213454 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |